Fe Absorption in Mother and Child Pairs From Wheat Fortified With Iron With and Without Phenolic Containing Beverages
Fe_Senegal
Evaluating the National Fortification Policy in Senegal Assessment of Iron Bio-availability in Mother and Child Pairs From Wheat Flour Fortified With Iron With and Without Phenolic Containing Beverages
1 other identifier
interventional
34
1 country
1
Brief Summary
In Senegal, iron deficiency affects 39% of and 82% of women and children between 12 and 50 months indicating that iron deficiency is a major health problem. The government of Senegal has implemented a flour fortification program including iron and folate. Iron is a difficult mineral to add to foods efficiently due to its organoleptic properties and typical low bioavailability in man. The aim of this study is to determine iron absorption from fortified wheat flour consumed with a phenolic containing beverage in women and child pairs. The fortificants used will be Ferrous Fumarate and Ferrous Sulfate, and the effect of absorption inhibitors on the bioavailability from iron compounds not readily bioavailable is poorly investigated. The bioavailability of the different iron compounds will be determined using stable iron isotopes. Sixteen pairs of women and children (n=34, children between 3-6 years, women between 18-45y) will be selected for participation in the study. After a screening, each women and child will receive 4 test meals consisting of a bread roll fortified stable isotopes with and without the tisane beverage. The first two test meals will be consumed on consecutive days. Two weeks after the second test meal a blood sample will be taken from each women and child before the third meal administration. After the forth test meal administration, and again two weeks later, the last blood sampling will take place and the study will be conducted for the subjects (duration 30 days). The samples will be sent to Zurich on dry ice for analysis for the following parameters: isotopic composition, H pylori infection, B vitamin status, Vitamin A status. In all samples, hemoglobin and iron status as well as inflammation status (CRP) will be determined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 15, 2015
CompletedFirst Posted
Study publicly available on registry
May 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedNovember 30, 2015
November 1, 2015
2 months
April 15, 2015
November 27, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Iron absorption measured as iron incorporation of stable isotopic labels in red blood cells 14 days after administration
The effect of the consumption of tea (phenolic containing beverages) will be assessed the two iron fortification compounds. The interaction between beverage and compound on iron absorption will be tested. The analysis will be separately conducted for mothers and children.
Up to 8 Months after study start
Secondary Outcomes (1)
Correlation between iron absorption in mother and child pairs
Up to 8 Months after study start
Study Arms (4)
FESO4+T
EXPERIMENTALFerrous sulfate fortified bread with tea
FESO4+W
EXPERIMENTALFerrous sulfate fortified bread with water
FeFu+T
EXPERIMENTALFerrous fumarate fortified bread with tea
FeFu+W
EXPERIMENTALFerrous fumarate fortified bread with water
Interventions
Fasting subjects will be served a wheat roll fortified with labelled ferrous sulfate and stable isotopes
Fasting subjects will be served a wheat roll fortified with labelled ferrous sulfate and stable isotopes
Fasting subjects will be served a wheat roll fortified with labelled Fe Fumarate and stable isotopes
Fasting subjects will be served a wheat roll fortified with labelled Fe Fumarate and stable isotopes
Eligibility Criteria
You may qualify if:
- Mother and child are willing to participate in the study jointly
- Body weight \< 65 kg
- ≤ BMI ≤ 25 (kg/m2)
- Non anemic (Hb ≥ 11,0 g/dl)
- Generally healthy and no chronic illnesses
- Non pregnant
- Non lactating
- No blood donation in the last 4 months
- No consumption of vitamin and nutritional supplements during and 2 weeks prior the study start.
- Age 3-6 years
- Generally healthy and no chronic illnesses
- no consumption of vitamin and mineral supplements during and 2 weeks prior the study start
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Université Cheikh Anta Diop
Dakar, Senegal
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ndeye Fatou Ndiaye, PhD
Université Cheikh Anta Diop de Dakar, Sengal
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2015
First Posted
May 8, 2015
Study Start
April 1, 2015
Primary Completion
June 1, 2015
Study Completion
October 1, 2015
Last Updated
November 30, 2015
Record last verified: 2015-11